Training in Research And Clinical Trials in Integrative Oncology (TRACTION)
A CIHR Funded Health Research Training Initiative
The TRACTION program is designed to provide trainees at all levels (undergraduate, graduate, postdoctoral) with a comprehensive, individualized training experience focussed on learning the essentials of research in psychosocial oncology, integrative oncology and behavioural clinical trials research.
Integrative Oncology is defined as an evidence-based sub-specialty that uses complementary therapies (such as mind-body therapies, energy therapies, natural health products, nutritional interventions and/or exercise) in concert with medical treatment to enhance its efficacy, improve symptom control, alleviate patient distress and reduce suffering.
Trainees will be accepted for one-year intervals and can re-apply each year that they are registered in a degree program. Each trainee will develop an individualized study program appropriate to their level of training based on a wide range of opportunities which could include salary support, fees for courses and training programs, conference expenses and travel funds.
Dr. Linda Carlson
Dr. Linda Carlson holds the Enbridge Research Chair in Psychosocial Oncology, is an Alberta Innovates-Health Solutions Health Scholar, Full Professor in Psychosocial Oncology in the Department of Oncology, Cumming School of Medicine at the University of Calgary, and Adjunct Professor in the Department of Psychology. She is the Director of Research and works as a Clinical Psychologist at the Department of Psychosocial Resources at the Tom Baker Cancer Centre.
Dr. Tavis Campbell
Tavis Campbell is a Professor of Clinical Psychology and Oncology at the University of Calgary, where he also holds the position of Director of Clinical training. He obtained his Ph.D from McGill University and completed a Postdoctoral Fellowship at Duke University Medical Centre. His research interests involve identifying and understanding the bio-behavioral mechanisms involved in the development, progression, and management of chronic diseases, such as hypertension, cancer and insomnia. Dr. Campbell has published results from several behavior-based RCTs in the areas of cancer, pain, and chronic disease management. In addition, he is actively involved in the Health Section of the Canadian Psychological Association and is Chair of the Adherence Committee for Hypertension Canada.
Dr. Nicole Culos-Reed
Dr. Nicole Culos-Reed is a Professor in Health and Exercise Psychology in the Faculty of Kinesiology, and a Professor in the Department of Oncology in the Faculty of Medicine, University of Calgary. Dr. Culos-Reed also holds a Research Associate appointment with the Department of Psychosocial Resources, Tom Baker Cancer Centre.
Dr. Janine Giese-Davis
Janine Giese-Davis received her B.A. in English Literature and B.S. in Psychology from Colorado State University and her M.A. and Ph.D. in Clinical Psychology from The University of Illinois, Urbana-Champaign. She is currently an Associate Professor in the Department of Oncology, Division of Psychosocial Oncology, Faculty of Medicine, at the University of Calgary, Alberta, Canada. She is also affiliated with the Department of Psychosocial Resources at the Tom Baker Cancer Centre, Calgary, Alberta. And she also holds an Adjunct Associate Professorship in the Department of Psychology, University of Calgary.
Dr. Fiona Schulte
Fiona’s research examines the psychosocial outcomes in children who have been diagnosed with cancer. More specifically, some work has been focused on developing an understanding of how survivors of childhood cancer perceive their social competence, and how one might accurately and reliably assess social competence in this population. This knowledge is critical to understanding social development in pediatric oncology survivors. Ultimately, Fiona is interested in investigating the mechanisms that lead to social competence deficits in this population, whether such deficits can be rehabilitated through psychosocial interventions, and if these interventions positively affect long-term survivorship.